analyst
PY
NASDAQ · PYXS
Pyxis Oncology, Inc. Common Stock
Healthcare · Biotechnology
$3.34
Up+$0.02 (+0.60%)
Updated Sep 17, 2026, 5:31 PM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 274.21M
- P/E ratio
- -2.84
- Dividend yield
- 0.00%
- 52-week range
- $1.03 – $5.55
- Volume
- 640.08K
- Avg. volume
- 793.75K
Price performance
PYXS price history
1M range · 20 trading sessions · Daily adjusted prices
PYXS closed at $3.34 after 20 trading sessions, down 0.89% for the selected period.
- Last close
- $3.34
- Period change
- -0.89%
- Period low
- $2.96
- Period high
- $3.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $3.34 | $3.42 | $3.32 | $3.34 | 640.08K |
| Sep 15, 2026 | $3.40 | $3.42 | $3.24 | $3.33 | 489.67K |
| Sep 14, 2026 | $3.21 | $3.515 | $3.21 | $3.43 | 699.69K |
| Sep 11, 2026 | $3.31 | $3.42 | $3.07 | $3.21 | 1.13M |
| Sep 10, 2026 | $3.42 | $3.4367 | $3.18 | $3.27 | 742.14K |
| Sep 9, 2026 | $3.48 | $4.12 | $3.132 | $3.38 | 4.35M |
| Sep 8, 2026 | $4.00 | $4.15 | $3.845 | $3.89 | 1.38M |
| Sep 4, 2026 | $3.53 | $4.05 | $3.515 | $3.89 | 2.23M |
| Sep 3, 2026 | $3.71 | $3.74 | $3.45 | $3.565 | 812.18K |
| Sep 2, 2026 | $3.45 | $3.77 | $3.435 | $3.75 | 731.71K |
| Sep 1, 2026 | $3.24 | $3.57 | $3.18 | $3.44 | 590.7K |
| Aug 31, 2026 | $3.20 | $3.28 | $3.0501 | $3.24 | 469.51K |
| Aug 28, 2026 | $3.32 | $3.3796 | $3.20 | $3.23 | 211.99K |
| Aug 27, 2026 | $3.31 | $3.37 | $3.23 | $3.32 | 396.78K |
| Aug 26, 2026 | $3.03 | $3.36 | $3.00 | $3.34 | 634.7K |
| Aug 25, 2026 | $2.96 | $3.09 | $2.94 | $3.06 | 422.22K |
| Aug 24, 2026 | $3.02 | $3.07 | $2.825 | $2.96 | 837.59K |
| Aug 21, 2026 | $3.15 | $3.21 | $3.02 | $3.08 | 682.28K |
| Aug 20, 2026 | $3.30 | $3.39 | $3.03 | $3.12 | 716.27K |
| Aug 19, 2026 | $3.07 | $3.50 | $3.06 | $3.37 | 1.04M |
Latest PYXS news
The latest Smart Investors Daily articles mentioning PYXS.
Stock researchResearch & News · Competitors
Loading stock research…

